Ironwood Pharmaceuticals (IRWD) Share-based Compensation (2010 - 2026)

Ironwood Pharmaceuticals (IRWD) has 17 years of Share-based Compensation data on file, last reported at $3.7 million in Q1 2026.

• For the quarter ending Q1 2026, Share-based Compensation rose 60783.33% year-over-year to $3.7 million; the trailing twelve-month figure through Mar 2026 stood at $7.6 million (down 44.58% YoY), and the FY2025 full-year result was $17.2 million, down 42.21% from the prior year.
• Share-based Compensation slipped to $3.7 million in Q1 2026, from $3.8 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $10.1 million in Q1 2024 to a low of -$19.3 million in Q4 2023.
• A 5-year average of $1.7 million and a median of $1.5 million in 2022 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation slumped 364.66% in 2023 and soared 63969.23% in 2024, its largest moves.
• Tracing IRWD's Share-based Compensation over 5 years: stood at $7.3 million in 2022, then tumbled by 364.66% to -$19.3 million in 2023, then soared by 123.66% to $4.6 million in 2024, then dropped by 16.27% to $3.8 million in 2025, then decreased by 4.45% to $3.7 million in 2026.
• Business Quant data shows IRWD's Share-based Compensation at $3.7 million in Q1 2026, $3.8 million in Q4 2025, and $1000.0 in Q3 2025.